test

Mark N. Lampert

@Bvf Inc Il

Latest period2024 - Q3ReportedManaged Assets$3.418BTotal holdings55
Assets growth rate-4.19%Assets growth rate (2-Q avg)-3.05%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Bvf Inc Il's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 55 positions.

Assets under management

The assets under management (AUM) of Bvf Inc Il over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.418B in assets, with a quarterly growth rate of -4.19% and a 2-quarter average growth rate of -3.05%. The portfolio is managed by Mark N. Lampert, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
MLTXMoonlake Immunotherapeutics
Recent Activity
32.09%
$1.097B
21.751M shares@ $50.42 avg price
KYMRKymera Therapeutics Inc
Recent Activity
7.15%
$244.308M
5.162M shares@ $47.33 avg price
RVMDRevolution Medicines Inc
Recent Activity
Decreased -41.84%
4.62%
$157.755M
3.479M shares@ $45.35 avg price
MIRMMirum Pharmaceuticals Inc
Recent Activity
Decreased -29.61%
3.51%
$119.96M
3.076M shares@ $39.0 avg price
TYRATyra Biosciences Inc
Recent Activity
3.21%
$109.585M
4.661M shares@ $23.52 avg price
OLMAOlema Pharmaceuticals Inc
Recent Activity
3.2%
$109.083M
9.136M shares@ $11.94 avg price
GPCRStructure Therapeutics Inc
Recent Activity
Decreased -9.99%
2.88%
$98.269M
2.239M shares@ $43.9 avg price
CGEMCullinan Therapeutics Inc
Recent Activity
2.82%
$96.266M
5.751M shares@ $16.74 avg price
XOMAXoma Royalty Corporation
Recent Activity
2.82%
$96.222M
3.634M shares@ $26.49 avg price
AXSMAxsome Therapeutics Inc
Recent Activity
Increased 9.53%
2.75%
$94.004M
1.046M shares@ $89.87 avg price